Epidermal growth factor (EGF), after binding to its receptor, activates a tyrosinespecific protein kinase which phosphorylates several substrates, including the EGF receptor itself. The ATP. These studies demonstrate that arylazido-p-alanyl-ATP interacts with the ATP-binding site of the EGF-receptor kinase with apparent high affinity and that this analogue is an effective photoaffinity label for the kinase. Furthermore, these studies demonstrate that the EGF receptor, identified by using monoclonal antibodies, contains an ATP-binding site, providing further confirmation that the EGF receptor and EGF-dependent protein kinase are domains of the Mr 170000 protein.
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receptor and activation of a tyrosine-specific . This protein kinase is believed to mediate the transmembrane signal of EGF binding, thereby initiating the cellular response to the hormone. The kinase is similar to the transforming gene product of the Rous sarcoma virus, p6OSRC, in that they are both tyrosine-specific protein kinases (Hunter & Sefton, 1980; Collett et al., 1980) with overlapping protein substrate specificities in vitro (Kudlow et al., 1981; Chinkers & Cohen, 1981 ; Pike et al., 1982) and in vivo (Hunter & Cooper, 1981) . Evidence has accumulated that the EGF receptor and the protein kinase are domains of the same molecule. The receptor and the kinase copurify , and variants of A431 cells with different quantities of receptors have corresponding alterations in protein kinase activity (Buss et al., 1982) . More direct evidence derives from the finding that FSBA, an ATP binding site affinity label, bound to proteins in A431 plasma membranes including an M, 170000 protein which corresponds in size to the EGF receptor (Buhrow et al., 1982 (Jeng & Guillory, 1975; Russell et al., 1976; Lunardi et al., 1977; Cosson & Guillory, 1979) and was chosen to label the EGF kinase because the azido-bearing side chain was at a position distinct from the triphosphate region of ATP, making substrate labelling less likely. Furthermore, after labelling we identified the receptor and kinase with a monoclonal antibody to the receptor (Kawamoto et al., 1983 Synthesis of arylazido-f3-alanyl-ATP Unlabelled arylazido-f-alanyl-ATP and its parent compound arylazido-p-alanine were synthesized and purified according to Jeng & Guillory (1975 Photoaffinity label of EGF kinase tubes to a final reaction volume of 50u1. In the standard experiments, 10 pm of the ATP analogue was used. Photoirradiation was carried out with a tungsten-halogen projection lamp (650W, DVY, 3400 K) with the sample at 15 cm from the lamp in an ice/water bath. The samples were irradiated for 30s intervals interspersed with 30s dark periods to prevent sample heating. In the standard experiments, the total light exposure time was 2 min. The tubes containing the unirradiated samples were wrapped completely in aluminium foil and exposed to light as described for the irradiated samples. After irradiation, the samples were brought to a volume of 0.5 ml with a solution containing 20mM-Hepes, pH7.2, and 5mM-EDTA, and centrifuged in a Microfuge (13 000g) for 5min. The membrane pellet was washed three times by centrifugation with reaction buffer prior to assay for EGF-dependent protein kinase activity.
Protein kinase activity in intact A431 plasma membranes was assayed as previously described Kudlow et al., 198 1 ; Buss et al., 1982) . Briefly, the membrane pellet was suspended in a 50u1 volume of reaction buffer. The reaction, which was carried out in an ice bath, was initiated by the addition of [y-32P]ATP (24uCi, 0.5pM) and terminated by the addition of 6-fold concentrated Laemmli (1970) sample buffer and boiling for 5min. In some experiments, the reaction was terminated by spotting the reaction mixture onto a filter paper disc which was dropped immediately into a solution of 10% (w/v) trichloroacetic acid containing 10mM-sodium pyrophosphate. The extent of phosphorylation was determined either by running the reaction mixture on a 7.5% SDS/polyacrylamide gel (Laemmli, 1970) followed by autoradiography or by determining, by liquid-scintillation counting, the amount of 32P precipitated onto the filter papers.
Photoaffinity labelling of the EGF-dependent protein kinase with arylazido-fl-alanyl-[a-32P1ATP
Photoaffinity labelling was performed exactly as described for photodependent inactivation except that 2 x 106 c.p.m. of the labelled azido-ATP analogue was added to each sample instead of unlabelled analogue. After irradiation, Weber & Osborn (1969) sample buffer was added to the reaction mixture and the samples were boiled for 2min prior to electrophoresis on a 4-10% SDS/polyacrylamide gel with the Weber & Osborn (1969) buffer system (sodium phosphate, pH7.0).
In some experiments, the EGF receptor was immunoprecipitated from solubilized plasma membranes which had been subjected to photoaffinity labelling. After irradiation, the membranes were solubilized in RIPA buffer containing EDTA (0.15 M-NaCl, 50mM-Tris/HCl, pH 7.2, 5mM-EDTA, 1% Triton X-100, 1% sodium deoxycholate and 0.1% SDS). After removal of non-solubilized material by centrifugation on a microcentrifuge, a monoclonal antibody to the EGF receptor was added to a final concentration of 10-6M and incubation was continued for 30min.
Formaldehyde-fixed Staphylococcus aureus, 15 yl of a 10% (w/v) suspension, was then added to the tubes and incubated for a further 30min. The entire mixture was layered onto a 0.75 ml cushion of 1 M-sucrose buffered with 20mM-Hepes, pH7.2, and centrifuged for 2.5 min. The bacterial pellet was washed twice by centrifugation with RIPA buffer, once with 0.5M-NaCl in 20mM-Hepes, pH 7.2, and once with water. The pellet was then boiled for 2min in Weber & Osborn (1969) sample buffer. The bacteria were removed by centrifugation and the supernatant was subjected to SDS/polyacrylamide-gel electrophoresis on a 4-10% gel with the Weber & Osborn (1969) buffer system. The gel was fixed and stained in 10% (v/v) propan-2-ol prior to drying. Autoradiographic exposure was carried out at -750C with an intensifying screen for 1-2 weeks.
In some experiments, the immunoprecipitate bound to the bacteria was treated with 10ul of 0.01 M-NaOH for 1 h at 370C. The alkali was neutralized with HCI prior to processing for gel electrophoresis.
Results and discussion
To determine whether arylazido-f-alanyl-ATP was capable of interacting with the ATP-binding site of the EGF-dependent kinase in a photodependent manner, unlabelled analogue was incubated with intact A431 plasma membranes with and without exposure to white light. The concentration of the analogue was varied from 1 to 30Mm and the time of exposure was fixed at 2min. After washing the membrane vesicles free of analogue, the activity of the protein kinase was determined by measuring its ability to phosphorylate the EGF receptor. No photodependent inactivation of the enzyme was observed in the absence of analogue (Fig. 1) . Some inactivation was observed on exposure of the kinase to 1 pM-analogue and maximal inactivation of the kinase occurred at an analogue concentration of 10pM (Fig. 1) . Therefore, the EGF-dependent protein kinase bound arylazido-3-alanyl-ATP with an apparent affinity between 1 and 10pM which is comparable with its affinity for ATP (Erneux et al., 1983) . If membrane vesicles were exposed to 100 pM-arylazido-fi-alanine, which had not been covalently bound to ATP, exposure to light resulted in no detectable alteration in kinase activity (Fig. 1, lanes A) . Con- light also did not result in decreased pr activity (Fig. 1, was not hydrolysed during the incubation with the vesicles (Yount et al., 1971) . GMP-PNP (20mM) was as effective as AMP-PNP at preventing the inactivation, confirming that guanosine nucleotides ,M-ATP and are also substrates for the EGF-dependent protein otein kinase kinase (Carpenter et al., 1978 activation was not observed. This incomplete protection may have resulted from competition between reversible binding by the nucleotides and covalent binding by the azido-ATP. It was unlikely to be due to indiscriminate inactivation by the analogue, since arylazido-fB-alanine at 10-fold the concentration of analogue had no effect on the kinase activity. The requirement that arylazido-,Balanine be linked to ATP to achieve photodependent inactivation, the high apparent affinity of the analogue for the kinase and the ability of AMP-PNP and GMP-PNP to protect against inactivation indicate that arylazido-p-alanyl-ATP is ATP-binding-site-specific and that the inactivation is not simply a result of light exposure or incubation with ATP.
To determine the M, of the EGF-receptor-associated peptide to which arylazido-p-alanyl-ATP binds, A431 membrane vesicles were photoaffinity labelled with arylazido-p-alanyl-[a-32P]ATP. Plasma membrane vesicles were prepared in such a way that proteolysis of the native receptor would be minimized . The pattern of labelled proteins obtained using the azido-ATP differed from that obtained using [y-32P]ATP (Fig.  4, lanes 1 and 3) , suggesting that the labelled proteins were ATP-binding proteins and not substrates. While several peptides were labelled, the most intensely labelled peptide had an M, of Irl:. 53000. The M, 53000 peptide has the same Mr as the fl-subunit of the (Na+ + K+ )ATPase (Spector et al., 1980 ) and a glycoprotein labelled by 8-azido-ATP in sarcoplasmic reticulum membranes (Campbell & MacLennan, 1983 To determine which of the proteins photoaffinity labelled by arylazido-f-alanyl-ATP was associated with the EGF receptor, the membrane vesicles were solubilized after labelling and the receptor was immunoprecipitated by using a monoclonal antibody to the receptor. Immunoprecipitates of the EGF receptor have been shown to contain EGF-dependent protein kinase activity . Immunoprecipitation of this labelled mixture of proteins effectively enriched for the receptor and associated protein kinase and revealed that only an M, 170000 labelled protein was specifically bound by the anti-receptor antibody (Fig. 4, lane 5) . This labelling of the receptor occurred at a concentration of about 40nM-arylazido-f-alanyl-[aC-32P]ATP, indicating a high affinity of the kinase for this analogue. The Mr 53000 protein also appeared in the immunoprecipitates, but its binding was not specific (Fig.  4 , lane 6), in that it appeared in immunoprecipitates with normal mouse serum. The labelling could be decreased by AMP-PNP (Fig. 4, lane 7) and GMP-PNP (Fig. 4, lane 8) indicating nucleotide-binding-site specificity. However, as in the photoinactivation studies, these nucleotides were not capable of completely blocking the labelling by the azido-ATP analogue. Incubation of the immunoprecipitate with alkali showed that the receptor label was labile (Fig. 4, lane 9) , a property of the ATP-i-alanine ester linkage but not of tyrosine phosphate (Fig. 4 , lanes 10 and 11) (Hunter & Sefton, 1980) . Furthermore, the labelling was strictly photodependent (Fig. 4, lanes 2  and 4) . Therefore, the labelling of the receptor resulted from linkage of the [a-32P] (Weber & Osbom, 1969) . The autoradiograms of the gel are shown (lanes 1 and 2). observed (Fig. 5, lanes 1 and 2) . However. when the receptor was labelled with arylazido-,B-alanyl-[a-32P]ATP, no effect of labelling was observed with EGF ( Fig. 5, lanes 3 and 4) . These studies demonstrate that arylazido-3-alanyl-ATP is an ATP-binding-site-specific photo-affinity label for the EGF-dependent protein kinase. The kinase has an apparent affinity for this analogue that is comparable with its affinity for ATP. The use of this analogue of ATP enabled us to probe the kinase at an alternative site to that probed by FSBA. These results suggest that the EGF receptor contains a domain that binds ATP, implying that the receptor and EGF-dependent protein kinase reside in the same polypeptide chain. However, because of the spacial proximity of the receptor and kinase, it is also possible that the receptor was labelled by this photoaffinity probe because of its substrate relationship to the kinase. The agreement of the results with this analogue and FSBA (Buhrow et al., 1982) , however, strengthen the argument that the receptor and kinase activities reside within the same molecule. Therefore, the EGF-receptor-kinase system resembles the insulin-receptor-kinase system (Roth & Cassel, 1983; Van Obberghen et al., 1983) , in which the insulin receptor and protein kinase also appear to reside in a single macromolecule.
Arylazido-,B-alanyl-ATP is a member of a family of azido-ATP analogues in which the length of the azido-bearing side chain can be varied (Jeng & Guillory, 1975) . The use of this class of analogues could therefore give important structural information about the EGF receptor kinase and may also be useful for probing other tyrosine-specific protein kinases. Such data coupled with sequence data would give further insight into the structurefunction relationships in this important molecule, and help provide a data base for comparison with other tyrosine-specific protein kinases.
